Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|
Icosavax, Inc. last posted its earnings results on Tuesday, November 14th, 2023. The company reported $-0.44 earnings per share for the quarter, topping analysts' consensus estimates of $-0.57 by $0.13. The company had revenue of 0 for the quarter and had revenue of 582,000 for the year. Icosavax, Inc. has generated $-2 earnings per share over the last year ($-2.23 diluted earnings per share) and currently has a price-to-earnings ratio of -15.78. Icosavax, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/14/2023 | Q3 2023 | -$0.57 | -$0.44 | 0.13 | $100,000 | $0 |
08/14/2023 | Q2 2023 | -$0.60 | -$0.59 | 0.01 | $0 | $0 |
05/10/2023 | Q1 2023 | -$0.60 | -$0.55 | 0.05 | N/A | $0 |
03/30/2023 | Q4 2022 | -$0.58 | -$0.54 | 0.04 | N/A | $0 |
11/14/2022 | Q3 2022 | -$0.57 | -$0.52 | 0.05 | N/A | $0 |
08/15/2022 | Q2 2022 | -$0.55 | -$0.56 | -0.01 | $1.20 M | $0 |
05/16/2022 | Q1 2022 | -$0.49 | -$0.59 | -0.1 | N/A | $0 |
03/30/2022 | Q4 2021 | -$0.42 | -$0.46 | -0.04 | N/A | $-5,732,000 |
11/15/2021 | Q3 2021 | -$0.49 | -$1.30 | -0.81 | $1.03 M | $1.83 M |
09/13/2021 | Q2 2021 | -$2.23 | -$2.86 | -0.63 | N/A | $1.90 M |
03/30/2021 | Q1 2021 | N/A | -$1.96 | N/A | N/A | $2.00 M |
12/30/2020 | Q4 2020 | N/A | -$1.60 | N/A | N/A | $0 |
09/29/2020 | Q3 2020 | N/A | -$1.87 | N/A | N/A | $0 |
06/29/2020 | Q2 2020 | N/A | -$1.74 | N/A | N/A | $0 |
03/30/2020 | Q1 2020 | N/A | -$0.23 | N/A | N/A | $0 |
Icosavax, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 based offlast year's report dates.
In the previous quarter, Icosavax, Inc. (:ICVX) reported $-0.44 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.57 by $0.13.
The conference call for Icosavax, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Icosavax, Inc.'s latest earnings report can be read online.
Icosavax, Inc. (:ICVX) has a recorded annual revenue of $582,000.
Icosavax, Inc. (:ICVX) has a recorded net income of $-88,458,000.Icosavax, Inc. has generated $-2.23 earnings per share over the last four quarters.
Icosavax, Inc. (:ICVX) has a price-to-earnings ratio of -15.78 and price/earnings-to-growth ratio is -4.34.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED